Entering text into the input field will update the search result below

Rigel Pharmaceuticals (RIGL +3.2%) signs an agreement to develop its R256 asthma drug with...

Jun. 19, 2012 11:16 AM ETRigel Pharmaceuticals, Inc. (RIGL) StockAZN, RIGLBy: Yigal Grayeff, SA News Editor

Rigel Pharmaceuticals (RIGL +3.2%) signs an agreement to develop its R256 asthma drug with AstraZeneca (AZN +3%) in a deal that could be worth $100M plus royalties if the treatment ever reaches market. There's still a long way to go, as R256 is yet to be tested on humans. (PR)

Recommended For You

More Trending News

About RIGL Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
RIGL--
Rigel Pharmaceuticals, Inc.